As a lysine acetyltransferase, ESCO1 is highly expressed in a variety of tumors, including bladder cancer, prostate cancer, and endometrial cancer;[36, 39] however, its role in cervical cancer has not been elucidated. This evidence concerns the gene ESCO1 and urinary bladder cancer.